[1] [1] FLEISCHMANN C, REICHERT F, CASSINI A, et al. Global incidence and mortality of neonatal sepsis: a systematic review and meta-analysis[J]. Arch Dis Child, 2021, 106(8): 745-752.

[2] [2] ZHOU B, ZHANG J, CHEN Y, et al. Puerarin protects against sepsis-induced myocardial injury through AMPK-mediated ferroptosis signaling[J]. Aging (Albany NY), 2022, 14(8): 3617-3632.

[4] [4] BI C F, LIU J, YANG L S, et al. Research progress on the mechanism of sepsis induced myocardial injury[J]. J Inflamm Res, 2022, 15: 4275-4290.

[5] [5] MA Z, DING Y, DING X, et al. PDK4 rescues high-glucose-induced senescent fibroblasts and promotes diabetic wound healing through enhancing glycolysis and regulating YAP and JNK pathway[J]. Cell Death Discov, 2023, 9(1): 424.

[6] [6] CHEN T, YE L, ZHU J, et al. Inhibition of pyruvate dehydrogenase kinase 4 attenuates myocardial and mitochondrial injury in sepsis-induced cardiomyopathy[J]. J Infect Dis, 2024, 229(4): 1178-1188.

[8] [8] DAI S, YE B, CHEN L, et al. Emodin alleviates LPS-induced myocardial injury through inhibition of NLRP3 inflammasome activation[J]. Phytother Res, 2021, 35(9): 5203-5213.

[9] [9] LIU A, ZHU Y, CHEN W, et al. PTEN dual lipid-and proteinphosphatase function in tumor progression[J]. Cancers (Basel), 2022, 14(15): 3666.

[10] [10] ZHANG L, LI B, LI W, et al. miR-107 attenuates sepsis-induced myocardial injury by targeting PTEN and activating the PI3K/AKT signaling pathway[J]. Cells Tissues Organs, 2023, 212(6): 523-534.

[11] [11] SINGER M, DEUTSCHMAN C S, SEYMOUR C W, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315(8): 801-810.

[12] [12] BOHNEN J M, MUSTARD R A, OXHOLM S E, et al. APACHE Ⅱ score and abdominal sepsis. A prospective study[J]. Arch Surg, 1988, 123(2): 225-229.

[13] [13] HOLLENBERG S M, SINGER M. Pathophysiology of sepsisinduced cardiomyopathy[J]. Nat Rev Cardiol, 2021, 18(6): 424-434.

[14] [14] LIU C, ZOU Q, TANG H, et al. Melanin nanoparticles alleviate sepsis-induced myocardial injury by suppressing ferroptosis and inflammation[J]. Bioact Mater, 2022, 24: 313-321.

[15] [15] KIM M J, SINAM I S, SIDDIQUE Z, et al. The link between mitochondrial dysfunction and sarcopenia: an update focusing on the role of pyruvate dehydrogenase kinase 4[J]. Diabetes Metab J, 2023, 47(2): 153-163.

[16] [16] THOUDAM T, CHANDA D, SINAM I S, et al. Noncanonical PDK4 action alters mitochondrial dynamics to affect the cellular respiratory status[J]. Proc Natl Acad Sci U S A, 2022, 119(34): e2120157119.

[17] [17] LIU B, ZHANG Y, SUO J. Increased expression of PDK4 was displayed in gastric cancer and exhibited an association with glucose metabolism[J]. Front Genet, 2021, 12: 689585.

[18] [18] DOU X, FU Q, LONG Q, et al. PDK4-dependent hypercatabolism and lactate production of senescent cells promotes cancer malignancy[J]. Nat Metab, 2023, 5(11): 1887-1910.

[19] [19] ZHENG Y, XU L, DONG N, et al. NLRP3 inflammasome: the rising star in cardiovascular diseases[J]. Front Cardiovasc Med, 2022, 9: 927061.

[20] [20] HE W, DONG H, WU C, et al. The role of NLRP3 inflammasome in sepsis: a potential therapeutic target[J]. Int Immunopharmacol, 2023, 115: 109697.

[21] [21] NGUYEN HUU T, PARK J, ZHANG Y, et al. Redox regulation of PTEN by peroxiredoxins[J]. Antioxidants (Basel), 2021, 10(2): 302.

[22] [22] ZHI D, ZHANG M, LIN J, et al. Role of HMGB1-PTEN signaling in T lymphocytes and monocytes upon sepsis[J]. Clin Lab, 2022, 68(5): DOI: 10.7754/Clin.Lab.2021.211024.